MetaCap

Inspire Medical Systems (INSP) vs PROCEPT BioRobotics (PRCT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

PROCEPT BioRobotics (PRCT) has outperformed Inspire Medical Systems (INSP) over the past year, losing 17.3% versus a loss of 38.7%. Over five years, PRCT leads with a -30.6% price change compared with -75.9% for INSP. Inspire Medical Systems is the larger company by market cap ($1.60 billion vs $1.42 billion), about 1.1 times the size, while PROCEPT BioRobotics is growing revenue faster (+37.2% vs +13.6%).

Inspire Medical Systems converts more of its revenue into profit, with a net margin of 15.9% versus -31.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INSP-38.69%PRCT-17.28%
+66%+2%-61%
Nov 21, 20251 yearNov 20, 2026
INSP-79.07%PRCT-39.28%
+155%+29%-96%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INSP versus PRCT key metrics
MetricINSPPRCT
Share price$55.10$24.70
Market cap$1.60B$1.42B
1-day change-2.10%-4.08%
YTD return-40.26%-21.49%
1-year return-38.69%-17.28%
5-year return-75.91%-30.64%
P/E ratio (TTM)16.45—
Forward P/E36.85—
EPS (TTM)$3.35$-2.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$911.98M$308.05M
Revenue growth (YoY)+13.60%+37.22%
Net income (latest FY)$145.42M$-95.57M
Gross margin85.39%63.70%
Operating margin5.59%-33.71%
Net margin15.95%-31.02%
52-week high$147.03$38.11
52-week low$38.91$16.67
Distance from 52-week high-62.52%-35.19%
Analyst consensusholdhold
Avg. price target upside+25.92%-7.89%
Average volume765.67K1.31M
Shares outstanding28.97M57.54M
Employees1,333888
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PRCT has outperformed INSP by 21.4 percentage points over the past year.
  • Inspire Medical Systems is more profitable, keeping 15.9 cents of every revenue dollar as net income versus -31.0 cents for PROCEPT BioRobotics.
  • PROCEPT BioRobotics grew revenue faster in its latest fiscal year (+37.22% vs +13.60%).

About Inspire Medical Systems

INSP stock →

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.

Health Care · Medical/Dental Instruments · 1,333 employees

About PROCEPT BioRobotics

PRCT stock →

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.

Health Care · Medical/Dental Instruments · 888 employees

INSP vs PRCT FAQ

Which is bigger, Inspire Medical Systems or PROCEPT BioRobotics?

Inspire Medical Systems (INSP) is larger, with a market capitalization of $1.60B compared with $1.42B for PROCEPT BioRobotics (PRCT).

Which stock has performed better over the past year, INSP or PRCT?

PRCT returned -17.28% over the past 12 months, compared with -38.69% for INSP (price return, excluding dividends). Past performance does not predict future results.

Are Inspire Medical Systems and PROCEPT BioRobotics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons